Time Is Now To Seek US Funding, Financing To Expand Domestic COVID-19 Vaccine Supply Chain
BARDA and Development Financing Corp. officials provide insights into window of opportunity for partnering on manufacturing scale-up.
You may also be interested in...
FlexBiosys wins award; others to follow. New capacity may also benefit manufacture of monoclonal antibodies and cell and gene therapies.
Distress grows as manufacturers wait for suppliers to boost production. One idea: stretch inventories by qualifying single-use bioreactors for reuse.
Agency requests proposals to boost surge capacity for single-use bags, tubing sets, vials, raw materials, vaccine plants.